Also this week, the NIH awarded the Oklahoma Medical Research Foundation (OMRF) three new grants totaling nearly $5.2 million to fund research initiatives in cancer, influenza and lupus. "These are three important, Oklahoma-grown ideas with disease relevance, so this is a tremendous achievement for us," said OMRF Vice President of Research Paul Kincade, Ph.D. "The grants represent fresh ideas that our scientists have developed over the past few years." He said the grants show the quality of biomedical research in the state. "Our competition for these funds includes Stanford, Harvard and other major institutions around the U.S.," he said. "So to successfully compete for these awards is a big deal."
Among the grant recipients at OMRF is Susan Kovats, Ph.D., who received a four-year, $1.7-million grant to study how dendritic cells in the lungs react to the influenza virus, an illness that kills an estimated 23,000 Americans each year. Her findings may help steer the development of new vaccine strategies.
Photo courtesy of OMRF